To cure chronic HIV infection, a new therapeutic strategy is needed (Q34360553)

1 August 2017

1 reference

title

To cure chronic HIV infection, a new therapeutic strategy is needed (English)

1 reference

1 August 2017

Smith KA

1

1 reference

1 August 2017

1 October 2001

1 reference

Current Opinion in Immunology

1 August 2017

1 reference

1 August 2017

13

1 reference

1 August 2017

5

1 reference

1 August 2017

617-624

1 reference

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Perspectives on inducing efficient immune control of HIV-1 replication--a new goal for HIV therapeutics?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Interleukin-2: inception, impact, and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Massive expansion of antigen-specific CD8+ T cells during an acute virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

The numbers game for virus-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Immune responses in interleukin-2-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

The interleukin-2 T-cell system: a new cell growth model.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Heterogeneity of human T-cell growth factor(s) due to variable glycosylation.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

T cell growth factor receptors. Quantitation, specificity, and biological relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

1 reference

7 January 2021

Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900270-3

7 January 2021

10.1016/S0952-7915(00)00270-3

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11544015